English
-
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
06/14/2024 - 07:00 PM
-
Pebblebrook Hotel Trust Declares Dividends for Second Quarter 2024
06/14/2024 - 07:00 PM
-
Glass Lewis Supports ALL of BlackRock’s Board Nominees and Rejects ALL of Saba’s Proposals to Terminate BlackRock as Investment Adviser at Contested CEF Annual Meetings
06/14/2024 - 07:00 PM
-
UnitedHealth Group Announces Earnings Release Date
06/14/2024 - 06:50 PM
-
Global Medical and Recreational Cannabis Database 2024 - ResearchAndMarkets.com
06/14/2024 - 06:45 PM
-
Invitation Homes Announces Cash Dividend
06/14/2024 - 06:45 PM
-
06/14/2024 - 06:43 PM
-
Global Petrochemical Market Report 2024: Petrochemical Market to Expand at 6.2% CAGR Through 2028, Supported by Growth in Polyethylene and Natural Gas Production - ResearchAndMarkets.com
06/14/2024 - 06:32 PM
-
RXO Names Troy Cooper to Board of Directors
06/14/2024 - 06:30 PM
-
SLB and Aker Carbon Capture Announce Closing of Carbon Capture Joint Venture
06/14/2024 - 06:30 PM
-
Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
06/14/2024 - 06:06 PM
-
Manchester United To Invest £50M in Carrington Training Facility To Create A Winning Environment
06/14/2024 - 06:00 PM
-
Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials
06/14/2024 - 06:00 PM
-
Fabrinet Appoints Forbes Alexander to Board of Directors
06/14/2024 - 06:00 PM
-
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
06/14/2024 - 06:00 PM